diaziquone has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukowski, R; Crawford, ED; Kirby, R; O'Bryan, RM; Rivkin, SE; Stephens, RL | 1 |
| Al-Sarraf, M; Decker, DA; Goldfarb, S; Kish, J | 1 |
2 other study(ies) available for diaziquone and Cancer of Kidney
| Article | Year |
|---|---|
High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Leukocyte Count; Platelet Count | 1986 |
Phase II clinical evaluation of AZQ in renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Thrombocytopenia | 1986 |